MODERN APPROACHES TO THE DIAGNOSTIC AND TREATMENT OF THE UROGENITAL SYNDROME

(Оглядова стаття)

Authors

DOI:

https://doi.org/10.11603/24116-4944.2023.2.14263

Keywords:

urogenital syndrome, perimenopausal period, vaginal atrophy, cystourethral atrophy, urinary incontinence, receptor apparatus of the urogenital tract, ozone therapy, urethrocystocervicopexy

Abstract

Perimenopausal disorders in the modern world is a significant problem of the female population from the point of view of increasing life expectancy and high activity of modern women of perimenopausal age. More than a third of women in perimenopause have urogenital disorders in the form of various manifestations of vaginal and cystourethral atrophy. The multicomponent complex of urogenital symptoms affects the lower third of the genital area, and the common origin of steroid-dependent areas explains the synchronicity of the disorders. In recent years, the peculiarities of the distribution and density of steroid receptors in the UG tract have been actively studied. Significant age-related changes were found in the density of nuclear receptors ERβ, ERα.

One of the most important factors that determines the nature and time of menopause is inhibin A and B. In the reproductive age, it supports the gonadotropin steroidal balance, the development of the dominant follicle. A decrease in the level of inhibin B is an early marker of the onset of menopause, and an increase in FSH is a secondary phenomenon, which indicates a long-term fading of the ovaries. The sequence of involution processes is pathogenetically associated with hemocirculation disorders, subsequent ischemia, dystrophy, a decrease in the proliferative activity of the epithelium, a glycogen deficiency, an increase in pH, and a violation of microbiocinosis. As a result, this is blue colpitis and dyspareunia. A decrease in collagen in the structures of the vagina and pelvic ligaments leads to prolapse of the bladder, urethra and stress incontinence. A change in the sensitivity and composition of muscarinic receptors of the urinary bladder and urethra also leads to the appearance of dysuric phenomena and urinary incontinence.

The diagnosis of patients with UGS depends on the patient's complaints. Gynecological examination, colposcopy, microscopic, microbiological examination - with symptoms of vaginal atrophy. Use of the Barlow scale to specify the degree of UGR-atrophy, assessment of the type, degree of urinary incontinence. Uroflowmetry - to assess the speed of bladder emptying, profilometry - reveals the presence of sphincter disorders.

Therapy of UG disorders has several directions. Local anti-inflammatory - taking into account the condition of the mucous membrane, the presence of flora, consists in the appointment of antiseptic baths, antibiotics in the form of creams, suppositories. Ozone-oxygen vaginal insufflation is aimed at improving microcirculation, rheological properties of blood, oxygenation of tissues, stimulation and regeneration of the epithelium, normalization of vaginal microbiocinosis, and improvement of immune status. The method allows to achieve high anti-inflammatory and pain-relieving effects, activates the body's own reserves. It is important to use hormonal preparations in the form of local forms of estriol, with fairly low doses, but a pronounced proliferative effect on the epithelium of the genitourinary tract, which are complemented by a gradual restoration of microflora, an angioprotective effect, improvement of muscle tone, and hyaluronization of ligaments.

Operative conservative methods are provided for patients with urinary incontinence. Training the muscles of the pelvic floor according to A. Kegel's technique – with a mild degree of stress urinary incontinence. Urethrocystocervicopepsies are operations used for cystocele and urethral hyperactivity. The average degree of stress incontinence is effectively corrected before the urethral injection of forming drugs. Severe stress incontinence requires sling urethropexic operations. Treatment of urge incontinence consists of muscarinic receptor antagonists to relax the detrusor, increase bladder filling, and decrease voiding frequency. Electrical stimulation of the pudendal nerve is used for overactive bladder with detrusor hypertonus. Sacral neuromodulation for urge incontinence stimulates regional conduction pathways, depresses the detrusor and improves pelvic floor muscle contractility.

Author Biographies

I. M. Shcherbina, Kharkiv National Medical University

Professor, doctor of medical science, Kharkov National Medical University

M. V. Strakhovetska, Kharkiv National Medical University

Professor, doctor of medical science, Kharkov National

References

Alperin, M., Burnett, L., Lukacz, E., & Brubaker, L. (2019). The mysteries of menopause and urogynecologic health: clinical and scientific gaps. Menopause (New York, N.Y.), 26(1), 103-111. DOI:10.1097/GME.0000000000001209. DOI: https://doi.org/10.1097/GME.0000000000001209

Cano, A. (2017). Menopause: A Comprehensive Approach. Springer International Publishing. DOI: 10.1007/978-3-319-59318-0. DOI: https://doi.org/10.1007/978-3-319-59318-0

Nappi, R. E., & Palacios, S. (2014). Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric : the journal of the International Menopause Society, 17(1), 3-9. DOI: 10.3109/13697137.2013.871696. DOI: https://doi.org/10.3109/13697137.2013.871696

Dennerstein, L., Dudley, E. C., Hopper, J. L., Guthrie, J. R., & Burger, H. G. (2000). A prospective population-based study of menopausal symptoms. Obstetrics and gynecology, 96(3), 351-358. DOI: 10.1016/s0029-7844(00)00930-3. DOI: https://doi.org/10.1097/00006250-200009000-00007

Gracia, C.R., & Freeman, E.W. (2018). Onset of the Menopause Transition: The Earliest Signs and Symptoms. Obstetrics and gynecology clinics of North America, 45(4), 585-597. DOI: 10.1016/j.ogc.2018.07.002. DOI: https://doi.org/10.1016/j.ogc.2018.07.002

Sharman Moser, S., Chodick, G., Bar-On, S., & Shalev, V. (2020). Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis. International journal of women's health, 12, 445-454. DOI: 10.2147/IJWH.S246113. DOI: https://doi.org/10.2147/IJWH.S246113

Shcherbina, I.M. (2010). Kliniko-patohenetychni pidkhody do diahnostyky, likuvannia ta profilaktyky perymenopauzalnykh porushen [Clinical-pathogenetic approaches to diagnosis, treatment and prevention of perimenopausal disorders]. Doctor’s thesis. Kharkiv [in Ukrainian].

Nelson, H. D., Haney, E., Humphrey, L., Miller, J., Nedrow, A., Nicolaidis, C., ... & Nygren, P. (2005). Management of menopause-related symptoms. Evidence report/technology assessment (Summary), (120), 1-6. PMID: 15910013; PMCID: PMC4782129. DOI: https://doi.org/10.1037/e439282005-001

Baroncini, D., Annovazzi, P. O., De Rossi, N., Mallucci, G., Torri Clerici, V., Tonietti, S., … Zaffaroni, M. (2019). Impact of natural menopause on multiple sclerosis: a multicentre study. Journal of neurology, neurosurgery, and psychiatry, 90(11), 1201-1206. DOI: 10.1136/jnnp-2019-320587. DOI: https://doi.org/10.1136/jnnp-2019-320587

Gandhi, J., Chen, A., Dagur, G., Suh, Y., Smith, N., Cali, B., & Khan, S. A. (2016). Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. American journal of obstetrics and gynecology, 215(6), 704-711. DOI: 10.1016/j.ajog.2016.07.045. DOI: https://doi.org/10.1016/j.ajog.2016.07.045

Dvornyk, V. (2013). Current topics in menopause. China: University of Hong Kong. Retrieved from: http://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=1121698. DOI: https://doi.org/10.2174/97816080545341130101

Calleja-Agius, J., & Brincat, M. (2012). The effect of menopause on the skin and other connective tissues. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 28(4), 273-277. DOI: 10.3109/09513590.2011.613970. DOI: https://doi.org/10.3109/09513590.2011.613970

Faubion, S.S., Kuhle, C.L., Shuster, L.T., & Rocca, W.A. (2015). Long-term health consequences of premature or early menopause and considerations for management. Climacteric: the journal of the International Menopause Society, 18(4), 483-491. DOI: 10.3109/13697137.2015.1020484. DOI: https://doi.org/10.3109/13697137.2015.1020484

Helsen, C., & Claessens, F. (2014). Looking at nuclear receptors from a new angle. Molecular and cellular endocrino­logy, 382(1), 97-106. DOI: 10.1016/j.mce.2013.09.009. DOI: https://doi.org/10.1016/j.mce.2013.09.009

Shcherbina, I.M. (2021). Perimenopausal syndrome: monograph. Kyiv: AUS Medicine Publishing.

Monteleone, P., Mascagni, G., Giannini, A., Genazzani, A.R., & Simoncini, T. (2018). Symptoms of menopause – global prevalence, physiology and implications. Nature reviews. Endocrinology, 14(4), 199-215. DOI: 10.1038/nrendo.2017.180. DOI: https://doi.org/10.1038/nrendo.2017.180

Pérez-López, Faustino R. (Ed.) (2019). Postmenopausal Diseases and Disorders. Springer International Publishing. DOI: 10.1007/978-3-030-13936-0. DOI: https://doi.org/10.1007/978-3-030-13936-0

Brotman, R.M., Shardell, M.D., Gajer, P., Fadrosh, D., Chang, K., Silver, M. I., Viscidi, R.P., Burke, A.E., Ravel, J., & Gravitt, P.E. (2018). Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause (New York, N.Y.), 25(11), 1321-1330. DOI: 10.1097/GME.0000000000001236. DOI: https://doi.org/10.1097/GME.0000000000001236

Farage, M.A., Miller, K.W., Woods, N.F., & Maibach, H.I. (2015). Skin, Mucosa and Menopause: Management of Clinical Issues. Springer. DOI: https://doi.org/10.1007/978-3-662-44080-3

Faubion, S.S., Sood, R., & Kapoor, E. (2017). Genitourinary Syndrome of Menopause: Management Strategies for the Clinician. Mayo Clinic proceedings, 92(12), 1842-1849. DOI: 10.1016/j.mayocp.2017.08.019. DOI: https://doi.org/10.1016/j.mayocp.2017.08.019

Flores, V.A., & Pal, L. (2018). Managing Menopause by Combining Evidence With Clinical Judgment. Clinical obstetrics and gynecology, 61(3), 496-507. DOI:10.1097/GRF.0000000000000384. DOI: https://doi.org/10.1097/GRF.0000000000000384

Kaunitz, A.M., & Manson, J.E. (2015). Management of Menopausal Symptoms. Obstetrics and gynecology, 126(4), 859-876. DOI: 10.1097/AOG.0000000000001058. DOI: https://doi.org/10.1097/AOG.0000000000001058

Borys, O.M., Suslikova, L.V., Sumenko, V.V., & Kolomeichuk, V.M. (2019). Novi mozhlyvosti korektsii dysbiotychnykh porushen mikrobiotsenozu pikhvy u zhinok v pery- ta postmenopauzi [New opportunities for correction of dysbiotic disorders of vaginal microbiocenosis in peri- and postmenopausal women]. Imunolohiia ta alerholohia – Immunology and Allergology, 1, 92-103 [in Ukrainian].

Tatarchuk, T.F., Pyrohova, V.I., Yefimenko, O.O., Bulavenko, O.V., Antonian, I.M., & Piliahina, H.Ya. (2018). Indyvidualizatsiia pidkhodiv do vedennia patsiientok u period menopauzalnoho perekhodu [Individualization of approaches to the management of patients during the menopausal transition]. Reproduktivnaya endokrinologiya – Reproductive endocrinology, 3, 8-11 [in Ukrainian]. DOI: https://doi.org/10.18370/2309-4117.2018.41.8-11

Horodenchuk, Z. (2019). Secho-statevyi syndrom menopauzy. Bezpeka ta efektyvnist suchasnykh pidkhodiv do likuvannia [Genitourinary syndrome of menopause. Safety and effectiveness of modern approaches to treatment]. Z turbotoiu pro zhinku – With care for a woman, 7, 48-50 [in Ukrainian].

Donska, Yu.V. (2018). Optymizatsiia terapii vulvovahinitiv u zhinok v menopauzi [Optimization of vulvovaginitis therapy in menopausal women]. Z turbotoiu pro zhinku – With care for a woman, 7, 16-17 [in Ukrainian].

Hutchinson-Colas, J., & Segal, S. (2015). Genitourinary syndrome of menopause and the use of laser therapy. Maturitas, 82(4), 342-345. DOI: 10.1016/j.maturitas.2015.08.001. DOI: https://doi.org/10.1016/j.maturitas.2015.08.001

Radkov, Y.V. (2017). Lechenye y profylaktyka retsydyvyruiushchykh ynfektsyi mochevikh putei u zhenshchyn v postmenopauzalnom peryode [Treatment and prevention of recurrent urinary tract infections in postmenopausal women]. Reproduktivnoye zdorovye, Vostochnaya Yevropa – Reproductive health, Eastern Europe, 7(3), 491-493 [in Russian].

Portman, D.J., Gass, M.L., & Vulvovaginal Atrophy Terminology Consensus Conference Panel (2014). Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause (New York, N.Y.), 21(10), 1063-1068. DOI: 10.1097/GME.0000000000000329. DOI: https://doi.org/10.1097/GME.0000000000000329

Chekman, I.S., Syrova, A.O., & Makarov, V.A. (2013). Ozon y ozonirovaniye [Ozone and ozonation]. Tsyfrova drukarnia №1 – Digital Printing House No. 1, 144 [in Russian].

Rueda, C., Osorio, A.M., Avellaneda, A.C., Pinzón, C.E., & Restrepo, O.I. (2017). The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review. Climacteric: the journal of the International Menopause Society, 20(4), 321-330. DOI: 10.1080/13697137.2017.1329291. DOI: https://doi.org/10.1080/13697137.2017.1329291

Popkov, O.V. (2021). Perevahy zastosuvannia mistsevoi formy estroheniv u likuvanni sechostatevoho syndromu menopauzy [Advantages of using topical estrogens in the treatment of genitourinary syndrome of menopause]. Ukrainskyi medychnyi chasopys – Ukrainian medical journal, 6(146), ХІ/ХІІ, 2-6 [in Ukrainian]. DOI: https://doi.org/10.32471/umj.1680-3051.146.223310

Raghunandan, C., Agrawal, S., Dubey, P., Choudhury, M., & Jain, A. (2010). A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women. The journal of sexual medicine, 7(3), 1284-1290. DOI: 10.1111/j.1743-6109.2009.01667.x. DOI: https://doi.org/10.1111/j.1743-6109.2009.01667.x

Chaika, K.V., Shalko, M.N., Stepanenko, T.O., & Zahorodnia, O.S. (2019). Osoblyvosti hormonalnoho homeostazu u zhinok z rannoiu menopauzoiu [Peculiarities of hormonal homeostasis in women with early menopause]. Visn. probl. biol. i medytsyny – Bulletin of the problem of biology and medicine, 1(1), 199-202 [in Ukrainian]. DOI: https://doi.org/10.29254/2077-4214-2019-1-1-148-199-202

Santoro, N., Roeca, C., Peters, B. A., & Neal-Perry, G. (2021). The Menopause Transition: Signs, Symptoms, and Management Options. The Journal of clinical endocrinology and metabolism, 106(1), 1-15. DOI: 10.1210/clinem/dgaa764. DOI: https://doi.org/10.1210/clinem/dgaa764

Datsko, H. (2019). Likuvannia sechostatevoho syndromu menopauzy [Treatment of genitourinary syndrome of menopause]. Z turbotoiu pro zhinku – With care for a woman, 5, 22-25 [in Ukrainian].

Baber, R.J., Panay, N., Fenton, A., & IMS Writing Group (2016). 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric : the journal of the International Menopause Society, 19(2), 109-150. DOI: 10.3109/13697137.2015.1129166. DOI: https://doi.org/10.3109/13697137.2015.1129166

Menopause: diagnosis and management (2019). National Institute for Health and Care Excellence (NICE).

Grant, M.D., Marbella, A., Wang, A.T., Pines, E., Hoag, J., Bonnell, C., Ziegler, K.M., & Aronson, N. (2015). Menopausal Symptoms: Comparative Effectiveness of Therapies. Agency for Healthcare Research and Quality (US).

Kronenberg, F., & Fugh-Berman, A. (2002). Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Annals of internal medicine, 137(10), 805-813. DOI: 10.7326/0003-4819-137-10-200211190-00009. DOI: https://doi.org/10.7326/0003-4819-137-10-200211190-00009

Published

2024-01-03

How to Cite

Shcherbina, I. M., & Strakhovetska, M. V. (2024). MODERN APPROACHES TO THE DIAGNOSTIC AND TREATMENT OF THE UROGENITAL SYNDROME: (Оглядова стаття). Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 84–90. https://doi.org/10.11603/24116-4944.2023.2.14263

Issue

Section

OBSTETRICS AND GYNECOLOGY